- Oct 16, 2020
Miro Health receives Breakthrough Device designation from the FDA
Miro Health has been granted breakthrough device designation by the Food and Drug Administration (FDA) for its mobile, self-administered,...
- Apr 20, 2020
Solving the neurological puzzle of COVID-19
Miro Health and Johns Hopkins have teamed up to investigate how COVID-19 affects the brain. Doctors on the frontlines of COVID-19 have...
- Aug 19, 2019
Patent granted to Miro Health for unsupervised assessment of neurological function
The design of digital interactions that can elicit consistent responses is a good challenge for any UI/UX professional. Pair that with...
- Jul 31, 2019
Miro Health files patent, positioning company to lead the charge on neurological phenotyping
Today, Miro Health filed a patent for the virtual identity verification tool for use in clinical trials. Virtual identity verification is...
- Aug 31, 2018
Researchers at Johns Hopkins show that Miro Health outpaces clinical care
Researchers at Johns Hopkins University Hospital have published study results in the American Journal of Speech and Language Pathology...
- Aug 23, 2017
Miro Health backed by Baseline and Felicis in $5.2M Seed Round
Baseline is joined by Felicis Ventures to back Miro Health and its sole female founder in a $5.2M Seed Round. The company sits at the...
- Jul 10, 2017
Miro Health gains patent approval for isolated measurement of biometric function
One approach to accurately assessing the health of a specific brain region involves isolating a single function or a set of functions solely
- Feb 1, 2017
Miro Health white paper shows Holy Grail of neurology within reach
The correct diagnosis of brain disorders is tricky; error rates fluctuate from 18% to 70% among specialists. In a recent study funded by ins
- Feb 2, 2015
Miro Health closes $500k Angel round
Sarah Imbach, a Silicon Valley insider, known for early operational roles at PayPal, LinkedIn, and 23andMe, has thrown her personal...
- Nov 30, 2014
Miro Health signs first customer
Genentech has become Miro's first customer. Founded in 1976, and acquired by Roche in 2009, Genentech has pioneered methods of treating...